Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 8 studies | 38% ± 17% | |
| myeloid cell | 5 studies | 23% ± 7% | |
| epithelial cell | 4 studies | 28% ± 12% | |
| astrocyte | 4 studies | 29% ± 8% | |
| glutamatergic neuron | 4 studies | 47% ± 16% | |
| microglial cell | 4 studies | 26% ± 4% | |
| monocyte | 4 studies | 26% ± 6% | |
| interneuron | 4 studies | 37% ± 21% | |
| dendritic cell | 3 studies | 18% ± 1% | |
| adipocyte | 3 studies | 20% ± 3% | |
| GABAergic neuron | 3 studies | 52% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 5% | |
| type I pneumocyte | 3 studies | 20% ± 2% | |
| alveolar macrophage | 3 studies | 23% ± 6% | |
| oligodendrocyte | 3 studies | 21% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 41% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1007.05 | 1445 / 1445 | 100% | 26.68 | 183 / 183 |
| pancreas | 100% | 988.29 | 328 / 328 | 100% | 19.46 | 178 / 178 |
| lung | 100% | 894.90 | 578 / 578 | 100% | 24.86 | 1154 / 1155 |
| breast | 100% | 690.41 | 459 / 459 | 100% | 21.96 | 1116 / 1118 |
| prostate | 100% | 830.19 | 245 / 245 | 99% | 27.05 | 499 / 502 |
| ovary | 99% | 449.57 | 179 / 180 | 100% | 18.42 | 429 / 430 |
| bladder | 100% | 735.48 | 21 / 21 | 99% | 20.64 | 499 / 504 |
| stomach | 100% | 659.92 | 359 / 359 | 99% | 15.44 | 283 / 286 |
| brain | 99% | 678.94 | 2615 / 2642 | 100% | 23.53 | 703 / 705 |
| intestine | 100% | 663.50 | 965 / 966 | 98% | 14.86 | 519 / 527 |
| thymus | 100% | 764.04 | 653 / 653 | 98% | 17.76 | 595 / 605 |
| uterus | 99% | 438.52 | 169 / 170 | 99% | 23.01 | 454 / 459 |
| skin | 100% | 1213.21 | 1809 / 1809 | 98% | 15.60 | 463 / 472 |
| kidney | 100% | 768.58 | 89 / 89 | 98% | 16.13 | 880 / 901 |
| adrenal gland | 100% | 970.20 | 258 / 258 | 92% | 11.05 | 212 / 230 |
| liver | 95% | 362.27 | 214 / 226 | 89% | 9.57 | 361 / 406 |
| muscle | 100% | 2142.72 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 573.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 28.36 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.00 | 1 / 1 |
| adipose | 100% | 760.66 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 548.94 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| heart | 95% | 877.59 | 817 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 912.95 | 765 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 78% | 6.02 | 62 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 3.44 | 17 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031923 | Biological process | pyridoxine transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0022857 | Molecular function | transmembrane transporter activity |
| Gene name | SLC49A4 |
| Protein name | Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2) DIRC2 protein (Solute carrier family 49 member 4) |
| Synonyms | DIRC2 |
| Description | FUNCTION: Mediates H(+)-dependent pyridoxine transport. . |
| Accessions | ENST00000261038.6 [Q96SL1-1] Q05BS2 Q96SL1 ENST00000477647.1 |